{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:55:49Z","timestamp":1782755749594,"version":"3.54.5"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Ultrasound in Obstet &amp; Gyne"],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To examine the distribution of maternal serum placental growth factor (<jats:styled-content style=\"fixed-case\">PlGF<\/jats:styled-content>) at 12, 22, 32 and 36 weeks' gestation in singleton pregnancies which develop pre\u2010eclampsia (<jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content>) and examine the performance of this biomarker in screening for <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum <jats:styled-content style=\"fixed-case\">PlGF<\/jats:styled-content> was measured in 40 212 cases at 11\u201313 weeks, in 10 282 cases at 19\u201324 weeks, in 10 400 at 30\u201334 weeks and 4043 at 35\u201337 weeks. Bayes' theorem was used to combine the <jats:italic>a\u2010priori<\/jats:italic> risk from maternal characteristics and medical history with serum <jats:styled-content style=\"fixed-case\">PlGF<\/jats:styled-content>. The performance of screening for <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> requiring delivery &lt; 32, at 32 + 0 to 36 + 6 and \u2265 37 weeks' gestation was estimated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In pregnancies that developed <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content>, serum <jats:styled-content style=\"fixed-case\">PlGF<\/jats:styled-content> was decreased and the separation in multiples of the median (<jats:styled-content style=\"fixed-case\">MoM<\/jats:styled-content>) values from normal was greater with earlier, compared to later, gestational age at which delivery for <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> became necessary. Additionally, the slope of the regression lines of <jats:styled-content style=\"fixed-case\">PlGF MoM<\/jats:styled-content> with gestational age at delivery in pregnancies that developed <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> increased with advancing gestational age at screening. The detection rates (<jats:styled-content style=\"fixed-case\">DRs<\/jats:styled-content>), at a false\u2010positive rate (<jats:styled-content style=\"fixed-case\">FPR<\/jats:styled-content>) of 10%, for <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> delivering &lt; 32 weeks were 79% and 97% with screening at 12 and 22 weeks, respectively. The <jats:styled-content style=\"fixed-case\">DRs<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> delivering at 32 + 0 to 36 + 6 weeks were 57%, 65% and 90% with screening at 12, 22 and 32 weeks. The <jats:styled-content style=\"fixed-case\">DRs<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> delivering \u2265 37 weeks were 40%, 37%, 54% and 64% with screening at 12, 22, 32 and 36 weeks, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The performance of combined screening with maternal factors, medical history and PlGF is superior in screening for early, compared to late, <jats:styled-content style=\"fixed-case\">PE<\/jats:styled-content> and improves with advancing gestational age at screening. Copyright \u00a9 2015 ISUOG. Published by John Wiley &amp; Sons Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/uog.15816","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T05:18:42Z","timestamp":1447910322000},"page":"472-477","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre\u2010eclampsia"],"prefix":"10.1002","volume":"47","author":[{"given":"A.","family":"Tsiakkas","sequence":"first","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cazacu","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wright","sequence":"additional","affiliation":[{"name":"Institute of Health Research University of Exeter  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wright","sequence":"additional","affiliation":[{"name":"Institute of Health Research University of Exeter  Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. H.","family":"Nicolaides","sequence":"additional","affiliation":[{"name":"Harris Birthright Research Centre for Fetal Medicine King's College Hospital  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"2005","volume-title":"Make every mother and child count. World Health Report","author":"World Health Organization","year":"2005"},{"key":"e_1_2_6_3_1","first-page":"2008","volume-title":"England, Wales and Northern Ireland","author":"Confidential Enquiry into Maternal and Child Health (CEMACH)","year":"2006"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2009.02.010"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e9322a"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.12421"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60736-4"},{"issue":"62","key":"e_1_2_6_8_1","first-page":"e1","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright D","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000338470"},{"key":"e_1_2_6_10_1","first-page":"e1","volume-title":"Am J Obstet Gynecol","author":"O'Gorman N","year":"2015"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.20.9267"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4004(97)90007-2"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod56.2.489"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1975.tb00710.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1994.04010034.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/10641950109152635"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14811"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15812"},{"key":"e_1_2_6_19_1","unstructured":"R Development Core Team. R. A language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria. 2011; ISBN 3\u2010900051\u201007\u20100 URLhttp:\/\/www.R\u2010project.org\/."},{"key":"e_1_2_6_20_1","unstructured":"TherneauT. A Package for survival analysis in S. R package version 2.37\u20107 2014;https:\/\/cran.r\u2010project.org\/web\/packages\/survival\/index.html."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/uog.6244"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.2660"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000359968"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324320"}],"container-title":["Ultrasound in Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fuog.15816","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/uog.15816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T07:17:05Z","timestamp":1696490225000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/uog.15816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1002\/uog.15816"],"URL":"https:\/\/doi.org\/10.1002\/uog.15816","archive":["Portico"],"relation":{},"ISSN":["0960-7692","1469-0705"],"issn-type":[{"value":"0960-7692","type":"print"},{"value":"1469-0705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]},"assertion":[{"value":"2015-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-03-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}